First report of mirtazapine-induced arthralgia

European Psychiatry

Volumn 16, Issue 8, 2001, Pages 503-505

  Jolliet, P ^a   Veyrac, G ^a   Bourin, M ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MIANSERIN; MIRTAZAPINE; NORSET;

ADULT; AGRANULOCYTOSIS; ARTHRALGIA; ARTICLE; BLOOD DISEASE; CASE REPORT; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; HYPERSENSITIVITY; IATROGENIC DISEASE; MALE; MYALGIA; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RASH; SEROTONINERGIC TRANSMISSION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARTHRALGIA; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0035678416     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(01)00614-9     Document Type: Article

References (12)

1. Drug-induced rheumatic disorders
2. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety
3. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
4. Mirtazapine: A review of its use in major depression
5. Arthropathy associated with treatment with mianserin
6. A risk-benefit assessment of mirtazapine in the treatment of depression
7. Mirtazapine and the granulocytes - So far so good
8. Safety and tolerability of the new antidepressants
9. Mianserin as a cause of arthritis
10. Hepatic injury caused by mianserin
11. Tolerability and patient compliance
12. Mirtazapine versus selective serotonin reuptake inhibitors